Abstract: Ubiquitin interacting motifs (UIMs) are short a-helices found in a number of eukaryotic proteins. UIMs interact weakly but specifically with ubiquitin conjugated to other proteins, and in so doing, mediate specific cellular signals. Here we used phage display to generate ubiquitin variants (UbVs) targeting the N-terminal UIM of the yeast Vps27 protein. Selections yielded UbV.v27.1, which recognized the cognate UIM with high specificity relative to other yeast UIMs and bound with an affinity more than two orders of magnitude higher than that of ubiquitin. Structural and mutational studies of the UbV.v27.1-UIM complex revealed the molecular details for the enhanced affinity and specificity of UbV.v27.1, and underscored the importance of changes at the binding interface as well as at positions that do not contact the UIM. Our study highlights the power of the phage display approach for selecting UbVs with unprecedented affinity and high selectivity for particular a-helical UIM domains within proteomes, and it establishes a general approach for the development of inhibitors targeting interactions of this type.
Introduction
Ubiquitin (Ub) is a highly abundant 76-amino acid protein that is expressed in every eukaryotic cell, and plays roles across a diverse range of cellular processes, including protein degradation, 1 DNA damage repair, 2,3 cell cycle regulation 4, 5 and a range of cell signaling pathways. 6 Ub exerts biological effects through covalent attachment to substrate proteins, in a process known as ubiquitination, or through non-covalent interactions with other proteins. Ubiquitination requires a coordinated cascade of reactions mediated by specialized enzymes (E1 activating enzymes, E2 conjugating enzymes and E3 ligating enzymes) to ultimately create an isopeptide bond between the C-terminal glycine residue of Ub and a lysine or a peptide bond with the free amino terminus on the substrate protein. The ubiquitination cascade can also add Ub to one of seven lysines or the amino terminus within Ub itself to produce chains of various linkages. Distinct downstream effects are mediated by ubiquitination, depending on differences in the number of Ub moieties attached to a substrate and on the type of side-chain linkages used when ubiquitin is iteratively attached to itself to form Ub chains. 1, 7, 8 Alternatively, Ub can interact with other proteins in a non-covalent manner through specialized Ub-binding domains (UBDs) imbedded within many proteins. These non-covalent interactions can facilitate the ubiquitination reaction itself or serve other regulatory roles. 9 Hundreds of UBDs have been found imbedded in functionally diverse proteins, either alone or in combination with Ub enzymes or other UBDs. [9] [10] [11] UBDs have been classified into over 20 structurally varied protein folds, which have been divided into five subfamilies: a-helices, zinc finger (ZnF) domains, Ub-conjugating like (Ubc-like) domains, Plekstrin homology (PH) domains, and "others." 11, 12 The a-helix subfamily is the largest, and it contains several distinct structural types, including Ubinteracting motifs (UIMs), motifs interacting with Ub (MIUs), double-sided UIMs (dUIMs), Ub-associated (UBA) domains, coupling-of-Ub-conjugation-toendoplasmic reticulum degradation (CUE) domains, GGA and TOM (GAT) domains, and Vps/Hrs/STAM (VHS) domains. 9, 12 Consisting of a single a-helix of approximately 20 amino acids, UIMs represent the smallest of the helical UBDs, 10 and they are widely distributed, with an estimated 12 or 60 UIMs predicted across 7 or 31 proteins in yeast and humans, respectively. 13, 14 Despite their diminutive size and simple structure, UIMs have been implicated in many critical cellular pathways, 12 including proteasomal degradation, 15 endosomal sorting, 16, 17 multivesicular body biogenesis, 9, 18 DNA repair, 19, 20 and DNA methylation. 21 In most cases, UIMs recognize ubiquitinated proteins directly and many proteins that contain UIMs are themselves ubiquitinated in a UIM-dependent manner. 22, 23 UIMs conform to a consensus sequence of e-e-x-x-u-x-x-A-ux-(u/e)-S-z-x-e (where e is an acidic residue, u is a hydrophobic residue, z is a bulky hydrophobic or polar residue with high aliphatic content, A is alanine, S is serine and x is a helix-favoring residue). 24 Numerous
Ub-UIM complex structures have been elucidated, revealing the basis for interaction. [24] [25] [26] In particular, Here we extend this work to explore whether the same approach can be applied to the small binding surface on Ub that mediates low affinity interactions with UIM alpha-helices. As a model system, we targeted the first of two UIMs in the yeast protein Vps27. We show that we can derive a UbV that binds to this UIM with an affinity that is improved almost 500-fold compared with that of wild-type Ub (Ub.wt). Moreover, the UbV exhibited high specificity for the cognate UIM relative to other yeast UIMs. We characterized the interaction between the UbV and UIM biochemically and structurally to understand the basis for enhanced affinity and specificity.
Results

UbV binders for the first UIM domain of Vps27
We used a biotinylated synthetic peptide representing the first UIM of the yeast protein Vps27 (yUIM-1) as the bait for binding selections with "library 2," a previously described phage-displayed library of UbVs. 31 Residues (arbitrarily numbered from 3 to 22) that conform to the UIM consensus are highlighted in grey, and the consensus is shown below (e is an acidic residue, u is a hydrophobic residue, z is a bulky hydrophobic or polar residue with high aliphatic content, A is alanine, S is serine, and x is a helix-favoring residue). "Sequence number" denotes the position of each UIM domain in the fulllength protein sequence according to the UniProt database. 14 IC 50 values were defined as the concentration of solution-phase GST-UIM fusion protein that inhibited 50% of the UbV.v27.1 binding to immobilized yUIM-1. "NDI" denotes "no detectable inhibition" with 60 mM GST-UIM.
Structure of UbV.v27.1 in complex with yUIM-1
To understand the molecular basis for how UbV.v27.1 binds to yUIM-1 with greatly enhanced affinity and specificity, we determined the crystal structure of the complex to 2.35 Å resolution (Table I , Fig. 2 ). Superposition of the complex structure with the NMR structure of the interaction of Ub.wt with yUIM- 1 24 showed that UbV.v27.1 bound to yUIM-1 in the same orientation as did Ub.wt [ Fig. 2 ) were in close proximity with their side-chains directed towards yUIM-1 [ Fig. 2(B) ], but surprisingly, individual back mutation of each of these four residues in UbV.v27.1 to the wt sequence revealed that only the Tyr 68 His substitution reduced affinity appreciably [17-fold, Fig. 3(A) ]. To assess whether these four residues exhibit cooperativity, we generated a quadruple mutant in which the four positions in UbV.v27.1 were simultaneously reverted to the wt sequence (Ile 8 His resulted in a UbV with almost no binding affinity for yUIM-1 at the concentration range tested. Thus, we concluded that the Tyr substitutions were both key mediators of the enhanced binding affinity of UbV.v27.1 for yUIM-1.
We also examined whether individual introduction of any of the substitutions from UbV.v27.1 into Ub.wt was sufficient to enhance the affinity for yUIM-1 [ Fig. 3(B Tyr caused a greater enhancement of binding (19 fold), but the resultant affinity (K d 5 6 lM) was still significantly lower than the affinity of UbV.v27.1 for yUIM-1.
Discussion
The large and diverse array of cellular processes regulated by the Ub system make ubiquitination an attractive process for therapeutic intervention. Design and implementation of phage-displayed libraries to identify UbVs that bind with enhanced affinity to specific targets has been a boon to such research. Recent applications of this approach have been successful in producing UbVs capable of modulating particular biological functions either as inhibitors or activators of Ub enzymes. [31] [32] [33] [34] Here, we have extended this body of work by applying the UbV technology to the UIM subfamily of UBDs.
UbV.v27.1 proved to bind tightly and specifically to yUIM-1 from yeast Vps27. UbV.v27.1 bound almost 500-fold more tightly to yUIM-1 than did Ub.wt (Fig.  3) , and binding was highly specific, as only one of the other 11 UIMs in the yeast proteome was recognized, and even its binding was 100-fold weaker [ Fig.  1(B) ]. The structure of UbV.v27.1 in complex with yUIM-1 revealed that the UbV binds in the same manner as Ub.wt, and only four of the 18 substitutions relative to Ub.wt have side-chains that are in close proximity to and point towards the UIM (Fig. 2) . Unexpectedly, mutagenesis studies of these four substitutions revealed that only the His 68 Tyr substitution contributed significantly to enhanced binding (Fig. 3) . Further investigation revealed that the Gly 10 Val substitution remote from the contact surface also contributed to the improved binding affinity for yUIM- of UbV.v27.1 for yUIM-1, it is less clear how the Gly 10 Val substitution exerts its influence. The Gly 10 Val substitution occurs in a tight turn between strands b1 and b2 of Ub.wt [ Fig. 2(B) ]. Comparison of this turn between UbV.v27.1 and Ub.wt reveals no obvious structural changes that propagate to the contact surface with yUIM-1, ruling out a simple allosteric mechanism. However, we note that the Thr 9 residue in the middle of the turn could not be unambiguously modeled. This observation may be indicative of an effect on the conformational dynamics of the UbV, as has been observed in the case of UbVs binding to USP14. 35 Overall, the influence of a non-contact residue on affinity emphasizes the complexity and limitations of rational design based on purely structure-based approaches, which further highlights the power of phage display technology to test billions of unique combinations in an unbiased manner.
In this study, we subjected Ub to variation to find a highly specific and potent binder for yUIM-1.
As there are a large number of UIMs with varying sequences and only a single conserved Ub, it would be interesting to perform the reverse experiment of subjecting a UIM to variation to find a high affinity binder to Ub. Understanding which residues of a UIM can be mutated to enhance affinity for Ub may give additional and complementary insight into the molecular basis for UIM-Ub interactions.
UbVs engineered for binding to several Ub enzymes have been shown previously to recognize their targets in vivo. [31] [32] [33] Importantly, these UbVs also affected the activity of these enzymes and consequently influenced cellular pathways in which the enzymes were involved. Mutation of yUIM-1 in Vps27 has been shown to cause defective sorting in multivesicular bodies, 18 and it may be interesting to determine if UbV.v27.1 can disrupt Vps27-dependent signaling in yeast cells. Even more intriguingly, the UbV strategy could be extended to targeting the 60 UIMs in the human proteome to reveal new biological functions and potential avenues for therapeutic intervention.
Methods
Selection and characterization of UbV-phage binding to yUIM-1
A peptide containing the first UIM of Vps27 (GGGGAADEEELIRKAIELSLKESRNSGGY) was biotinylated with N-hydroxysuccinimidyl d-biotin-15-amido-4, 7, 10, 13-tetraoxapentadecylate (NHS-PEO 4 -Biotin) in accordance with the manufacturer's instructions (Thermo Fisher Scientific). The biotinylated peptide was immobilized in 96-well NuncImmuno MAXISORP plates (Thermo Scientific) coated with streptavidin (New England Biolabs), and phage pools representing UbV library 2 31 were cycled through five rounds of binding selections with the immobilized peptide, as described. 36, 37 UbVphage clones that bound to the peptide but not to streptavidin or BSA were identified by clonal phage ELISAs and were subjected to DNA sequence analysis to decode the sequences of the displayed UbVs, as described.
31
Expression and purification of GST-UIM fusion proteins
A comprehensive list of 12 yeast UIM domains was curated through annotated domain sites found in the SMART and Uniprot databases. 13, 14 Mutagenic oligonucleotides (Supporting Information Table S1 ) were designed to insert DNA encoding for each UIM in to the pHH0103(TEV) vector (a gift from Cheryl Arrowsmith, Addgene plasmid # 64660) by sitedirected mutagenesis using standard methods 36, 38, 39 to create open reading frames encoding for the UIM fused to the carboxy terminus of 6xHis-GST. Plasmids designed to express the GST-UIM fusion proteins were transformed into Escherichia coli BL21(DE3) and single colonies were used to inoculate 5 ml selective 2YT media and cultures were grown overnight with shaking at 378C. The cultures were used to inoculate 1 L selective 2YT media and were grown with shaking at 378C to midlog phase (OD 600 0.8). Protein expression was induced by the addition of 100 mM IPTG (Bio Basic), the temperature was lowered to 188C, and cultures were incubated overnight with shaking. Bacteria were pelleted and resuspended in 20 ml Lysis Buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 10% glycerol, 10 mM imidazole, 1 mg/ml Lysozyme (BioShop Canada), 0.5% Triton-X 100, 20 U/ml Benzonase (EMD Millipore), and protease inhibitor cocktail (Sigma-Aldrich)). Cells were lysed by sonication, and protein purification was performed by incubating cell lysates with 1 ml slurry Ni-NTA resin (Qiagen) and eluting proteins with an imidazole buffer gradient ranging from 30 to 300 mM. The purity of eluted fractions were confirmed by SDS-PAGE, and protein concentrations were determined from OD 280 measurements with extinction coefficient from ExPASy ProtParam. 40 
Expression and purification of UbV proteins
For crystallography, the gene encoding for UbV.v27.1 was cloned into the expression vector pHH0239 (a gift from Cheryl Arrowsmith, Addgene plasmid # 51323) to produce an open reading frame encoding for UbV.v27.1 with an N-terminal 6xHis-tag and an intervening cleavage site for the Tobacco Etch Virus (TEV) protease, as well as a C-terminal GAAA motif. The plasmid was transformed into E. coli BL21(DE3), a single colony was used to inoculate 5 ml selective 2YT media, and the culture was grown overnight with shaking at 378C. The culture was used to inoculate 1 L selective 2YT media, and 6xHis-UbV.v27.1 protein was expressed and purified as described above for GST-UIM fusion proteins. Purified 6xHis-UbV.v27.1 was dialyzed into TEV Cleavage Buffer (50 mM Tris pH 8.0, 1 mM 1,4-Dithiothreitol (DTT), 0.5 mM EDTA) and digested overnight with TEV protease at a 1:100 molar ratio of protease:substrate to remove the 6xHis-tag as described. 33 UbV.v27.1 protein was purified by applying the reaction mixture to Ni-NTA resin and collecting the unretained fractions. Protein purity was assessed by SDS-PAGE, and UbV.v27.1 protein was concentrated and buffer-exchanged into FPLC Buffer (PBS pH 7.4, 1 mM DTT) using Amicon Ultra-4 concentrators with a 3 kDa cutoff (EMD Millipore). The protein was further purified by gel filtration using the € AKTA system (GE Healthcare) equipped with a Hi-Load 16/60 Superdex 75 size exclusion column (GE Healthcare Life Sciences). Protein purity was verified by SDS-PAGE, and UbV.v27.1 protein was concentrated as described above. Final assessment of purity was performed by SDS-PAGE, and protein concentration was determined from OD 280 measurement with extinction coefficient from ExPASy ProtParam. 40 For fluorescence polarization experiments, UbV.v27.1 was cloned into pHH0239 and Ub.wt was cloned into pProEX-HTA (Life Technology) for expression as TEV cleavable N-terminally 6xHis-tagged fusions proteins. Both proteins were expressed in E. coli BL21(DE3) as previously described. Cells were resuspended in Lysis buffer (50 mM HEPES pH 7.5, 5mM imidazole, 500 mM NaCl, 5mM b-mercaptoethanol, 5% glycerol) and lysed by sonication. Cell lysate was loaded onto a 1-ml HiTrap Chelating HP column (GE Healthcare) and eluted by an imidazole buffer gradient ranging from 5 to 300 mM. Fractions containing UbV.v27.1 or Ub.wt were pooled, dialyzed in Dialysis buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 5 mM b-mercaptoethanol) to remove imidazole, and incubated overnight with TEV protease to cleave the 6xHis tag. After overnight incubation, TEV protease and uncleaved UbV.v27.1 or Ub.wt were removed by applying the reaction mixtures to a 1-ml HiTrap Chelating HP column (GE Healthcare). UbV.v27.1 or Ub.wt in the flow through fractions was concentrated with a 3 kDa cutoff Amicon Ultra-4 concentrator (EMD Millipore) and resolved by size exclusion chromatography (SEC) on a Superdex 75 16/600 column (GE Healthcare) previously equilibrated with 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT. Peaks corresponding to UbV.v27.1 or Ub.wt were pooled together, concentrated and flash frozen to 2808C. Mutants of UbV.v27.1 and Ub.wt were purified in the same manner. The quadruple UbV.v27.1 mutant eluted as a double peak during SEC. In this case, each peak was collected, concentrated, flash frozen and assayed for binding to yUIM-1 separately.
Crystallization, structure determination, refinement and analysis A peptide corresponding to residues 256-278 of the Vps27 protein from Saccharomyces cerevisiae, with a non-native N-terminal Tyr residue to aid concentration determination by A 280 measurement (YPE-DEEELIRKAIELSLKESRNSA, Genscript), was suspended in sterile water for irrigation (Braun Medical, Inc). The peptide solution was mixed in a 1:1 molar ratio with a UbV.v27.1 protein solution to a final concentration of 500 mM. One microliter UbV.v27.1/peptide solution was mixed with 1 ll mother liquor containing 2.1 M DL-Malic acid pH 7.0, and incubated as hanging drops over lower wells containing 350 ll mother liquor. Crystals were harvested after 17 days, placed in mother liquor supplemented with 25% glycerol (vol/vol), and flash frozen in liquid nitrogen.
A single crystal dataset was collected at 21808C on a home-source consisting of a Rigaku MicroMax-007 HF rotating anode generator coupled to a Rigaku Saturn 944 HG CCD detector, and was processed using HKL2000. 41 The structure was solved by molecular replacement using PHASER 42 and a search model of one molecule of yUIM-1 (PDB ID 1Q0W) and one molecule of Ub with the 5 C-terminal residues removed (PDB ID 1UBQ). The structure was refined by REFMAC 43 and PHENIX, 44 both using TLS parameters, 45 and manual building in COOT. 46 Interactions between yUIM-1 and UbV.v27.1 were analyzed using the protein interfaces, surfaces and assemblies (PISA) tool. 47 could not be modeled.
Competitive phage ELISAs
Competitive phage ELISAs were performed as described. 33 Briefly, GST-yUIM-1 fusion protein was immobilized in a 384-well Nunc MAXISORP plate (Thermo Scientific) and the plate was blocked with BSA. A sub-saturating concentration of UbV.v27.1-phage was incubated for 1 h at 258C with serial dilutions of GST-UIM fusion protein and the mixtures were transferred to the plate containing immobilized GST-yUIM-1. After 15 min of incubation, the plates were washed and bound phages were labeled with a-M13 antibody/HRP conjugate (1:5,000 dilution, GE Healthcare Life Sciences) for 30 min. The plate was washed and developed with 3,3 0 ,5,5 0 -Tetramethylbenzidine Peroxidase Substrate solution (SeraCare), and absorbance at 450 nm was measured using a PowerWave XS plate reader (BioTek). Data were plotted with the Prism 6 software (GraphPad Software Inc) and curves were fitted using a one-site binding Hill model. IC 50 values were determined as the concentration of solution-phase GST-UIM protein that reduced 50% binding of UbV.v27.1-phage to immobilized GST-yUIM-1.
Fluorescence polarization binding experiments
A peptide corresponding to residues 256-278 of Vps27 (YPEDEEELIRKAIELSLKESRNSAK, Bio Basic Inc.) was suspended in 100 mM HEPES pH 7.5, 100 mM NaCl. Subsequently, pH was adjusted to 6.5 by adding 1 M NaOH and 14.8 M ammonium hydroxide to approximate final concentrations of 5 mM and 30 mM, respectively. The peptide contained a non-native N-terminal tyrosine to aid concentration determination and a non-native Cterminal lysine to allow covalent labeling with 5/6-carboxyfluorescein succinimidyl ester (NHS-FITC) (Bio Basic Inc.). The C-terminus was amidated and the N-terminus was acetylated to prevent charge effects from the termini affecting peptide binding. Peptide concentration was determined from absorbance measurement at 495 nm using the extinction coefficient of FITC (75,000 L mol 21 cm
21
). Binding measurements were performed in FP buffer (25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01 mg/ ml BSA, 0.03% BRIJ-35) by mixing in a 96-well plate 25 nM FITC-labeled yUIM-1 peptide with serial dilutions of Ub.wt and its variants ranging from 1 mM to 22 nM. For UbV.v27.1 and its variants, binding measurements were performed similarly with concentrations varying from 50 mM to 0.28 nM. Samples were equilibrated at room temperature for 30 min before reading plates on a HTS Multi-Mode Microplate Reader (Synergy Neo) using an excitation filter of 485 nm and an emission filter of 530 nm. Dissociation constants were determined with Prism (GraphPad Software Inc) using a one-site total binding model. For the quadruple mutant of UbV.v27.1, which eluted as two distinct peaks by SEC, binding measurements were made on both species.
Accession Number
Coordinate and structure factors for the UbV.v27.1-yUIM-1 complex have been deposited in the Protein Data Bank with accession number 5UCL.
